IP Library Assignment 035902/0191
Patent Assignment
Reel/Frame 035902/0191

Release of Security Interest

Recorded: 2015-06-12 Pages: 53
Assignor
OXFORD FINANCE LLC
Executed: 2015-06-11
Assignee
CYTORI THERAPEUTICS, INC.
3020 CALLAN ROAD, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (36)
Systems and Methods for Treating Patients with Processed Lipoaspirate Cells
Patent: 7,501,115 →
Application: 10/614,392 →
Publication: US 2004/0096431
Systems and Methods for Treating Patients with Processed Lipoaspirate Cells
Patent: 7,473,420 →
Application: 10/614,431 →
Publication: US 2004/0097867
Method for Processing Lipoaspirate Cells
Patent: 7,429,488 →
Application: 10/614,643 →
Publication: US 2005/0074436
Self-Contained Adipose Derived Stem Cell Processing Unit
Patent: 7,390,484 →
Application: 10/614,644 →
Publication: US 2004/0106196
Autologous Adipose Tissue Implant with Concentrated Stem Cells
Patent: 8,119,121 →
Application: 10/614,648 →
Publication: US 2005/0260174
Adipose-Derived Stem Cells and Lattices
Patent: 7,470,537 →
Application: 10/740,315 →
Publication: US 2005/0153441
Systems and Methods for Separating and Concentrating Adipose Derived Stem Cells from Tissue
Patent: 7,514,075 →
Application: 10/877,822 →
Publication: US 2005/0084961
Methods of Using Regenerative Cells in the Treatment of Musculoskeletal Disorders
Patent: 7,771,716 →
Application: 10/884,637 →
Publication: US 2005/0048644
Automated Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Patent: 7,585,670 →
Application: 10/884,638 →
Publication: US 2005/0260175
Methods of Using Adipose Derived Stem Cells to Treat Acute Tubular Necrosis
Patent: 8,404,229 →
Application: 10/884,639 →
Publication: US 2005/0048033
Methods of Using Adipose Derived Stem Cells to Promote Wound Healing
Patent: 8,105,580 →
Application: 10/884,860 →
Publication: US 2005/0048034
Method for Processing and Using Adipose-Derived Stem Cells
Patent: 7,595,043 →
Application: 10/885,293 →
Publication: US 2005/0058632
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
Patent: 9,597,395 →
Application: 11/138,083 →
Publication: US 2006/0083720
Systems and Methods for Treating Patients with Processed Lipoaspirate Cells
Patent: 7,687,059 →
Application: 11/584,202 →
Publication: US 2007/0036768
Systems and Methods for Manipulation of Regenerative Cells Separated and Concentrated from Adipose Tissue
Application: 12/302,787 →
Publication: US 2009/0304644
Systems and Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Patent: 8,163,276 →
Application: 12/554,755 →
Publication: US 2010/0136668
Syringe System for Controlled Delivery or Removal of Material
Application: 12/766,768 →
Publication: US 2010/0268189
Systems, Methods and Compositions for Optimizing Tissue and Cell Enriched Grafts
Patent: 9,133,431 →
Application: 12/771,985 →
Publication: US 2010/0279405
Methods of Using Adipose Derived Regenerative Cells to Promote Restoration of Intevertebral Disc
Patent: 9,504,716 →
Application: 12/853,110 →
Publication: US 2010/0303774
Methods of Making Enhanced, Autologous Fat Grafts
Patent: 7,887,795 →
Application: 12/886,341 →
Publication: US 2010/0330673
Methods of Making Enhanced, Autologous Fat Grafts
Patent: 7,901,672 →
Application: 12/886,353 →
Publication: US 2011/0003388
Methods of Using Adipose Tissue-Derived Cells in the Treatment of the Lymphatic System and Malignant Disease
Patent: 8,784,801 →
Application: 13/031,031 →
Publication: US 2011/0206646
Methods of Making Enhanced, Autologous Fat Grafts
Patent: 8,337,834 →
Application: 13/042,334 →
Publication: US 2011/0158968
Methods of Using Regenerative Cells to Promote Wound Healing
Patent: 8,691,216 →
Application: 13/360,022 →
Publication: US 2012/0121556
Syringe System for Controlled Delivery or Removal of Material
Application: 13/450,262 →
Publication: US 2012/0259289
Systems and Methods for Isolating and Using Clinically Safe Adipose Derived Regenerative Cells
Patent: 8,883,499 →
Application: 13/452,349 →
Publication: US 2012/0264200
Devices and Methods for Monitoring, Managing, and Servicing Medical Devices
Application: 13/467,828 →
Publication: US 2012/0221253
Methods of Using Regenerative Cells in the Treatment of Stroke and Related Diseases and Disorders
Patent: 9,511,094 →
Application: 13/586,735 →
Publication: US 2012/0308518
Methods of Using Adipose-Derived Regenerative Cells in the Treatment of Peripheral Vascular Disease and Related Disorders
Patent: 9,480,718 →
Application: 13/587,700 →
Publication: US 2012/0315257
Methods of Using Adipose Tissue-Derived Cells in Augmenting Autologous Fat Transfer
Patent: 8,771,678 →
Application: 13/588,989 →
Publication: US 2012/0308536
Cell Carrier and Cell Carrier Containment Devices Containing Regenerative Cells
Application: 13/598,203 →
Publication: US 2013/0060338
Adipose-Derived Stem Cells and Lattices
Application: 13/712,546 →
Publication: US 2013/0217118
Use Adipose Tissue-Derived Regenerative Cells in the Modulation of Inflammation in the Pancreas and in the Kidney
Application: 13/720,829 →
Publication: US 2013/0108592
Adipose-Derived Regenerative Cells for Treating Liver Injury
Patent: 9,198,937 →
Application: 13/725,814 →
Publication: US 2013/0121974
Methods of Using Adipose Derived Regenerative Cells in the Treatment of Renal Diseases and Disorders
Patent: 9,504,718 →
Application: 13/849,900 →
Publication: US 2013/0344035
Isolated Human Adipose-Derived Stem Cells
Application: 13/852,463 →
Publication: US 2013/0224858
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Dec 3, 2012
From: CYTORI THERAPEUTICS INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 029395/0660 →
Security Agreement Jun 28, 2013
From: CYTORI THERAPEUTICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 030715/0625 →
Release of Security Interest Jul 3, 2013
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 030734/0778 →
Assignment of Assignor's Interest Sep 10, 2013
From: CYTORI THERAPEUTICS, INC.
To: PUREGRAFT LLC
Reel/Frame 031174/0029 →
Assignment of Assignor's Interest Oct 25, 2013
From: CYTORI THERAPEUTICS, INC.
To: PUREGRAFT LLC
Reel/Frame 031482/0815 →
Assignment of Assignor's Interest Sep 10, 2014
From: CYTORI THERAPEUTICS, INC.
To: BIMINI TECHNOLOGIES LLC
Reel/Frame 033715/0803 →
Security Interest Sep 22, 2017
From: CYTORI THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 043952/0150 →
Assignment of Assignor's Interest Apr 11, 2019
From: BIMINI TECHNOLOGY LLC
To: PUREGRAFT LLC
Reel/Frame 048861/0926 →
Assignment of Assignor's Interest Apr 25, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049651/0001 →
Release of Security Interest Apr 25, 2019
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 049011/0347 →
Assignment of Assignor's Interest May 17, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049313/0434 →
Corrective Assignment to Correct the Correct Assignee's Address Previously Recorded at Reel: 049313 Frame: 0434. Assignor(S) Hereby Confirms the Assignment. Aug 1, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049942/0204 →
Corrective Assignment to Correct the Conveying Party Name Previously Recorded at Reel: 48861 Frame: 926. Assignor(S) Hereby Confirms the Assignment. Sep 24, 2019
From: BIMINI TECHNOLOGIES LLC
To: PUREGRAFT LLC
Reel/Frame 050481/0043 →
Confirmatory Assignment Oct 14, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 050724/0450 →
Conditional Assignment Oct 29, 2019
From: CYTORI THERAPEUTICS, INC.
To: BIMINI TECHNOLOGIES LLC
Reel/Frame 050852/0910 →
Assignment of Assignor's Interest Nov 1, 2019
From: BIMINI TECHNOLOGIES LLC
To: PUREGRAFT LLC
Reel/Frame 050888/0878 →